Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
VALN Valneva
13.402-0.138-1.02%
Close
01/31 16:00 ET
High
13.790
Open
13.790
Turnover
75.73K
Low
13.402
Pre Close
13.540
Volume
5.61K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
EMA Published Clinical Data Supporting Use Of Covid-19 Vaccine Valneva In Adults Aged 18 To 50
EMA Published Clinical Data Supporting Use Of Covid-19 Vaccine Valneva In Adults Aged 18 To 50
Oppenheimer Emerging Biotech Analyst to Hold Analyst/industry Conference Call
Analyzing Valneva (NASDAQ:VALN) & Titan Pharmaceuticals (NASDAQ:TTNP)
Valneva (NASDAQ:VALN – Get Rating) and Titan Pharmaceuticals (NASDAQ:TTNP – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses
Valneva (NASDAQ:VALN) Trading Down 4.1%
Valneva SE (NASDAQ:VALN – Get Rating)'s share price fell 4.1% on Tuesday . The company traded as low as $14.63 and last traded at $14.63. 2,420 shares were traded during mid-day trading, a decline o
Valneva SE (NASDAQ:VALN) Short Interest Up 48.4% in December
Valneva SE (NASDAQ:VALN – Get Rating) was the recipient of a large increase in short interest during the month of December. As of December 30th, there was short interest totalling 31,900 shares, an
VALNEVA - Declaration of Shares and Voting Rights: Status on December 31, 2022 (Corrected Data) and January 4, 2023
VALNEVA Declaration of shares and voting rightsStatus on December 31, 2022 (corrected data) and January 4, 2023_________________________________________________________________________________________
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why
Valneva (NASDAQ:VALN) Shares Gap Down to $14.04
Valneva SE (NASDAQ:VALN – Get Rating)'s share price gapped down before the market opened on Friday . The stock had previously closed at $14.04, but opened at $13.37. Valneva shares last traded at $13
VALNEVA - Declaration of Shares and Voting Rights: December 31, 2022
VALNEVA Declaration of shares and voting rightsDecember 31, 2022 __________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 ru
What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock
Company Overview
More
Valneva SE is a specialty vaccine company. The firm focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. It takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. It operates through the following segments: Commercialized products, COVID, Vaccine candidates and Technologies and services. The Commercialized products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment engages in the development, manufacturing and distribution related to COVID-19 vaccine candidate, VLA2001. The Vaccine candidates segment engages in proprietary research and development programs aiming to generate new approvable products in order to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies, excluding COVID-19 vaccine candidate, VLA2001. The Technologies and services segment provides services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.
CEO： Mr. Thomas Lingelbach
Market： NASDAQ
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet